Graham Capital Management »

Ultragenyx Pharmaceutical shares owned by Graham Capital Management

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $663k 14k 47.82
2022-09-30 $245k 5.9k 41.27

More positions owned by Graham Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Microstrategy Cl A New Put Option (MSTR)
Zillow Group Note 0.750% 9/0 (Principal)
Microstrategy Note 0.750%12/1 (Principal)
Permian Resources Corp Note 3.250% 4/0 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Transocean Deb 4.000%12/1 (Principal)
Bill Holdings Note 12/0 (Principal)
Opko Health Note 4.500% 2/1 (Principal)
Bloom Energy Corp Note 2.500% 8/1 (Principal)
Maxeon Solar Technologies Lt SHS Call Option (MAXN)
Maxeon Solar Technologies Lt Note 6.500% 7/1 (Principal)
Zscaler Note 0.125% 7/0 (Principal)

View all positions for Graham Capital Management

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
Wellington Management Company
T. Rowe Price Associates
Federated Investors
ClearBridge Advisors
Alliancebernstein
Marshall Wace
Baker Bros. Advisors
Deutsche Bank Aktiengesellschaft
Bank of New York Mellon
Avidity Partners Management
Norges Bank Investment Management
First Light Asset Management
Jacobs Levy Equity Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Ultragenyx Pharmaceutical